Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3487972019 | Product containing metformin and repaglinide (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3715705010 | Metformin- and repaglinide-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing metformin and repaglinide (medicinal product) | est un(e) (attribut) | répaglinide | true | Inferred relationship | Some | ||
| Product containing metformin and repaglinide (medicinal product) | est un(e) (attribut) | Product containing metformin (medicinal product) | true | Inferred relationship | Some | ||
| Product containing metformin and repaglinide (medicinal product) | est un(e) (attribut) | Combination oral hypoglycemic (product) | false | Inferred relationship | Some | ||
| Product containing metformin and repaglinide (medicinal product) | a pour principe actif (attribut) | Repaglinide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing metformin and repaglinide (medicinal product) | a pour principe actif (attribut) | Metformin (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Metformin and repaglinide only product | est un(e) (attribut) | True | Product containing metformin and repaglinide (medicinal product) | Inferred relationship | Some | |
| Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet | est un(e) (attribut) | False | Product containing metformin and repaglinide (medicinal product) | Inferred relationship | Some | |
| Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | False | Product containing metformin and repaglinide (medicinal product) | Inferred relationship | Some | |
| Metformin- and repaglinide-containing product in oral dose form | est un(e) (attribut) | True | Product containing metformin and repaglinide (medicinal product) | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR